CompletedPhase 4NCT03546634

Sero-conversion Study for a Two-dose Schedule of Sabin IPV in China

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centers for Disease Control and Prevention, China
Principal Investigator
Zijian Feng
Centers for Disease Control and Prevention, China
Intervention
Sabin IPV(biological)
Enrollment
280 target
Eligibility
All sexes
Timeline
2018 – 2020

Study locations (1)

Collaborators

Shandong Province Centers for Disease Control and Prevention

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03546634 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis →

← Back to all trials